Protective benefits of Alzheimer's and cancer may lead to new diagnostic treatments

NewsGuard 100/100 Score

People who have Alzheimer's disease may be less likely to develop cancer, and people who have cancer may be less likely to develop Alzheimer's disease, according to a new study published in the December 23, 2009, online issue of Neurology®, the medical journal of the American Academy of Neurology.

"Discovering the links between these two conditions may help us better understand both diseases and open up avenues for possible treatments," said study author Catherine M. Roe, PhD, of Washington University School of Medicine in St. Louis, MO, and a member of the American Academy of Neurology.

For the study, researchers looked at a group of 3,020 people age 65 and older who were enrolled in the Cardiovascular Health Study and followed them for an average of five years to see whether they developed dementia and an average of eight years to see whether they developed cancer. At the start of the study, 164 people (5.4 percent) already had Alzheimer's disease and 522 people (17.3 percent) already had a cancer diagnosis.

During the study, 478 people developed dementia and 376 people developed invasive cancer. For people who had Alzheimer's disease at the start of the study, the risk of future cancer hospitalization was reduced by 69 percent compared to those who did not have Alzheimer's disease when the study started. For Caucasian people who had cancer when the study started, their risk of developing Alzheimer's disease was reduced by 43 percent compared to people who did not have cancer at the start of the study, although that finding was not evident in minority groups. .

http://www.aan.com.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New trials show promise for immune checkpoint blockers in early-stage lung cancer